ࡱ> PO  \pMegan Gordon Don Ba==K[;#8X@"1qArial1qArial1qArial1qArial1qArial1QqTahoma1QqTahoma1@qArial1@qArial1h8qCambria1,8qCalibri18qCalibri18qCalibri1qCalibri1qCalibri1<qCalibri1>qCalibri1?qCalibri14qCalibri14qCalibri1 qCalibri1 qCalibri1qArial1qCalibri1qCalibri1 qCalibri1qCalibri1qArial1qArial1qArial1@qArial1 qArial1$qArial1qArial1xqArial"$"#,##0_);\("$"#,##0\)!"$"#,##0_);[Red]\("$"#,##0\)""$"#,##0.00_);\("$"#,##0.00\)'""$"#,##0.00_);[Red]\("$"#,##0.00\)7*2_("$"* #,##0_);_("$"* \(#,##0\);_("$"* "-"_);_(@_).))_(* #,##0_);_(* \(#,##0\);_(* "-"_);_(@_)?,:_("$"* #,##0.00_);_("$"* \(#,##0.00\);_("$"* "-"??_);_(@_)6+1_(* #,##0.00_);_(* \(#,##0.00\);_(* "-"??_);_(@_) 0.0%% "$"#,##0.0_);[Red]\("$"#,##0.0\)                                                                      ff + ) , *  !    P  P         `            a>   (@ @ "8@ @   (@ @   h@ @   & ,@ @  &"<@ @  "<@ @  h@ @   & l@ @   &"|@ @   "<@ @     "  "|@ @   "<@ @  "8@ @   ,@ @  "<@ @   ,@ @  "|@ @   "|@ @   "<@ @  "<@ @ * *8@ @ *x@ @   "<@ @   " ! ) ! #  "8@@ "8@ "8 @  20% - Accent1 20% - Accent2 20% - Accent3 20% - Accent4 20% - Accent5 20% - Accent6 40% - Accent1 40% - Accent2 40% - Accent3 40% - Accent4 40% - Accent5 40% - Accent6 60% - Accent1 60% - Accent2 60% - Accent3 60% - Accent4 60% - Accent5! 60% - Accent6 "Accent1 #Accent2 $Accent3 %Accent4 &Accent5 'Accent6(Bad) Calculation* Check Cell+,-./Explanatory Text0  1Good2 Heading 13 Heading 24 Heading 35 Heading 46 7Input8 Linked Cell 9Neutral :Note ;Output< =Title >Total? Warning Text`'4Chart - 5 Yr Surv & $ Per DeathP Data Sheet%pChart - for top 5 cxr killers  ; "f^fH( @rj0 3 A@@ C'LungColonProstateLiverLeukemia EsophagusUrinary BladderNon-Hodgkin LymphomaKidneyOvarianUterine CorpusBrainDeaths Incidence 5 yr survBreast (female)+- PANCREATICMelanoma of the skinOral cavity & pharynxThyroidMyelomaStomachUterine Cervix $ per DeathNCI Funding (in millions)No snapshot availableiUnless otherwise noteed, all statistical data is from the American Cancer Society's 2008 Facts & Figures.@1. caonline.amcancersoc.org/cgi/content/full/CA.2007.0010v1/FIG893. http://seer.cancer.gov/statfacts/html/mulmy_print.html'2. http://www.abc2.org/statistics.shtmlT4. ACS: Trends in 5-Year Rel Survival Rates by Race & Yr of Diagnosis, US, 1975-200359% 6$6. No NCI funding snapshot available97% 4, 672% 1, 6I5. NCI snapshot doesn't differentiate funding for Hodgkin and non-HodgkinH(NCI snapshot doesn't differentiate funding for Hodgkin and non-Hodgkin)*o n0/cc||]!}-}; 0.0\)_(*}A}1 0.0\)_(*;_(@_) }A}2 0.0\)_(*?;_(@_) }A}3 0.0\)_(*23;_(@_) }-}4 0.0\)_(*}A}0 a0.0\)_(*;_(@_) }A}( 0.0\)_(*;_(@_) }A}7 e0.0\)_(*;_(@_) }}5 ??v0.0\)_(*̙;_(@_)    }}9 ???0.0\)_(*;_(@_) ??? ??? ??? ???}}) }0.0\)_(*;_(@_)    }A}6 }0.0\)_(*;_(@_) }}* 0.0\)_(*;_(@_) ??? ??? ??? ???}-}= 0.0\)_(*}x}80.0\)_(*;_(??? ??? ???}-}/ 0.0\)_(*}U}< 0.0\)_(*;_( }A}" 0.0\)_(*;_(}A} 0.0\)_(*ef;_(}A} 0.0\)_(*L;_(}A} 0.0\)_(*23;_(}A}# 0.0\)_(*;_(}A} 0.0\)_(*ef;_(}A} 0.0\)_(*L;_(}A} 0.0\)_(*23;_(}A}$ 0.0\)_(*;_(}A} 0.0\)_(*ef;_(}A} 0.0\)_(*L;_(}A} 0.0\)_(*23;_(}A}% 0.0\)_(*;_(}A} 0.0\)_(*ef;_(}A} 0.0\)_(*L;_(}A} 0.0\)_(*23;_(}A}& 0.0\)_(*;_(}A} 0.0\)_(*ef;_(}A} 0.0\)_(*L;_(}A}  0.0\)_(*23;_(}A}' 0.0\)_(* ;_(}A} 0.0\)_(*ef ;_(}A} 0.0\)_(*L ;_(}A}! 0.0\)_(*23 ;_(M 20% - Accent1 ef %M" 20% - Accent2 ef %M& 20% - Accent3 ef %M* 20% - Accent4 ef %M. 20% - Accent5 ef %M2 20% - Accent6  ef %M 40% - Accent1 L %M# 40% - Accent2 L湸 %M' 40% - Accent3 L %M+ 40% - Accent4 L %M/ 40% - Accent5 L %M3 40% - Accent6  Lմ %M 60% - Accent1 23 %M$ 60% - Accent2 23ٗ %M( 60% - Accent3 23֚ %M, 60% - Accent4 23 %M0 60% - Accent5 23 %M4 60% - Accent6  23 %AAccent1 O %A!Accent2 PM %A%Accent3 Y %A)Accent4 d %A-Accent5 K %A1Accent6  F %9Bad  % Calculation  }%  Check Cell  %????????? ??? Comma( Comma [0]&Currency. Currency [0]G5Explanatory Text %;Good  a%G Heading 1 I}%OG Heading 2 I}%?G Heading 3 I}%239 Heading 4 I}%uInput ̙ ??v% K Linked Cell }%ANeutral  e%"Normalb Note  wOutput  ???%????????? ???$Percent1Title I}%MTotal %OO? Warning Text %XTableStyleMedium9PivotStyleLight16B   {9  dMbP?_*+%&Gz?MHP LaserJet 10204 oXX\??)\(?0z%@4x%%q%%SDDMHP LaserJet 1020-(d"PX??Uv(  p  6NMM?`]`    MHP LaserJet 10204 oXXSDDMHP LaserJet 1020-(d"dXX??3@z3d23 M NM4 3Q .5 Year Survival RatesQr ;Q ;Q3_  NM   4E4 3Q  $ Per DeathQ ;Q ;Q3_ 3f9 NM  3f3f994E4D $% Mp 3O&Q4$% Mp 3O&Q4FA7 93O 3 boPP PZaajkR R R RR RV VdDL#M-S S43*?4% %]fMZ3O&Q .5 Year Survival Rates'4523  43" H3O% M$3OQ444S S4A7 93O3 boR RR RV VdDL! MS S43*#M4% ,]xMZ3ON&Q  $ Per Death'43" 4S S4% QQM@3O9&Q GFive Year Cancer Survival Rates Compared to NCI Dollars Spent per Death'4S S 4e PANCREATIC PANCREATICLiverLiverLungLung Esophagus EsophagusStomachStomachBrainBrainMyelomaMyelomaOvarianOvarianLeukemiaLeukemia Colon Colon Kidney Kidney1 Non-Hodgkin Lymphoma1 Non-Hodgkin Lymphoma' Urinary Bladder' Urinary Bladder% Uterine Corpus% Uterine Corpus'Breast (female)'Breast (female)1Melanoma of the skin1Melanoma of the skinProstateProstatee?u@?ܪ@333333?p@+?@Q?@9v?x@(\?@?@?fce@ {Gz? T@ (\? @ HzG? @ ? Ni^ @ (\? J@{Gz?bC6@Q? @Gz?a7Z$@e ZR  C A@P]` ll  s *U A@ < x]`Ut  !<"Lethal & Under-Researched Cancers<"!>@7ggD&   !UdIe  dMbP?_*+%:7&C&18Most Common Causes of Cancer Incidence & Mortality&?'(\?))\(?MHP LaserJet 10204 oXXSDDMHP LaserJet 1020-(d"SX??U} %K} mK} IK} L}  K} K} $L}  L} $L} ]} $ !Column IColumn HColumn G!   *W                              @A~ a`@bbbbbc XY X X X X X X X ^ GC~ Hf@ I~ H@@ H~ M@%Tu@ϰAD~ S@ @C~ D@ E~ D@ DN@Uܪ@J$@ GC~ H`? A I~ HA HM@Tp@S.@ @C~ D@ E~ D@ DN@U@F+? @C~ D@E~ D@@BZ'@V@J8@]? @ C~ DL@ E~ D@ DNI`@~ Ux@F9v?~  ]@ @C~ Dt@E~ D@DN>@U@FA@]@ @  C~ D$@ E~ DP@ D N@U@JF@ @ C~ D@ E~ D3@ D~ Nk@% Ufce@AD  J?]@ G C~ H`b@ I~ He@ H~ M@% TT@ @WAD ~ SP@ @ C~ D@ E~ Di@ D N@U@F`P@ @ C~ D$@ E~ D@ D N`@U@JS@_@ & @C~ D@ E~ D@ D~ N@%UNi^ @ EwAD~ JT@ @ C~ D@ E~ D.@ DNffffff3@UJ@JT@ GC~ HEA I~ H@ HME@%TbC6@0lAD~ S@V@ @CP@4(kQ~ Pr@BV[@V @JV@ GC~ HA I~ H@ H~ M@%Ta7Z$@yAD~ SX@ @C~ R=@Q~ P@ BOV J!  _ @C~ D@E~ D<@ BOV J$  _ @C~ P;@Q~ Pؘ@ BOV J#  _ ` `[[\[[\\\ `[[\[[\\\ `[[\[[\\\ ` [[\[[\\\ `%[[\[[\\\ `"[[\[[\\\[[\[[\\\[[\[[\\\BX2rllxjjllxwjjj((((((  [[[\[[\\\00 (  ~  <rXPP? _]4@r NpJ/لM 6<7Megan Gordon Don: http://www.abc2.org/statistics.shtml<n6)%~~  <|rXPP?Am_]4@|r XǵG`Դ+ <Megan Gordon Don: Most funding levels are from the NCI snapshots that are available on-line. Some are from 2006, and some from 2007. <nG~~  <rXPP? @  _]4@r Ҍ^ M!5Zq H<IMegan Gordon Don: http://seer.cancer.gov/statfacts/html/mulmy_print.html<nH~~  <DsXPP? @ ]4@Ds BajGD0QI c<dMegan Gordon Don: ACS: Trends in 5-Year Rel Survival Rates by Race & Yr of Diagnosis, US, 1975-2003<nc~~  <sXPP? @  _]4@s EfC&GI:n>V c<dMegan Gordon Don: ACS: Trends in 5-Year Rel Survival Rates by Race & Yr of Diagnosis, US, 1975-2003<nc~~  < tXPP? @ _]4@ t ]QŰJ=%;F O<PMegan Gordon Don: caonline.amcancersoc.org/cgi/content/full/CA.2007.0010v1/FIG8<nEO~~  <ptXPP? @ ]4@pt ӮTJ9ݠB O<PMegan Gordon Don: caonline.amcancersoc.org/cgi/content/full/CA.2007.0010v1/FIG8<nEOvRaMegan Gordon Don.Megan Gordon Don.Megan Gordon Don.Megan Gordon Don. Megan Gordon Don.Megan Gordon Don.Megan Gordon Don.>@<dA   7ggD&bn   tq  dMbP?_*+%"bn??U  (   j  0NMM?p]`   "??3пz3d23 M NM4 3Q .5 Year Survival RatesQ3 +)'::: ::Q3+)'::: ::Q3_4E4 3Q  $ Per DeathQ3+)'::: ::Q ;Q3_4E4D $% Mp 3O&Q4$% Mp 3O&Q4FA?6 = 3O 3 boPP PZaajkR R R RR RV VdDL#MS S43*4% ,]cMZ3O&Q .5 Year Survival Rates'4523  43" ?3O% M$3OQ444S S4A?6 = 3O3 boR RR RV VdDL! MS S43*#M4% ]vMZ3ON&Q  $ Per Death'43" 4S S4% QM@3O&Q l4Cancer 5 Year Survival Rates Compared to $ per Death'4S S 4e PANCREATIC PANCREATICLungLiverColonLung'Breast (female) EsophagusProstateStomache?u@333333?p@{Gz?T@{Gz?bC6@Gz?a7Z$@e >@7ggD& Oh+'0HPl Megan Gordon DonMegan Gordon DonMicrosoft Excel@(@Ⱥt@_>7՜.+,0L PXh px PanCAN'  Chart - 5 Yr Surv & $ Per Death Data SheetChart - for top 5 cxr killers'Data Sheet'!Print_Area  Worksheets Named Ranges  !"#$%&'()*+,-./0123456789:;<=>@ABCDEFHIJKLMNRoot Entry FC;Workbook}SummaryInformation(?DocumentSummaryInformation8G